Featured Publications
Flavivirus - Zika and DENV
Nature Communications
Nature Communications
Single dose of chimeric dengue-2/Zika vaccine candidate protects mice and non-human primates against Zika virus Baldwin et al. 2021 Nature Communications 12, 7320
Plos Neglected Tropical Diseases
Plos Neglected Tropical Diseases
Antigenicity, stability, and reproducibility of Zika reporter virus particles for long-term applications Whitbeck et al. 2020 PLoS Neglected Tropical Diseases 14, e0008730
Scientific Reports
Scientific Reports
Complete Protection in Macaques Conferred by Purified Inactivated Zika Vaccine: Defining a Correlate of Protection Young et al. 2020 Scientific Reports 10, 3488SARS-CoV-2
Nature Communications
Nature Communications
A stapled lipopeptide platform for preventing and treating highly pathogenic viruses of pandemic potential Bird et al. 2024 Nature Communications 15, 274
Vaccines
Vaccines
A Phase I/II clinical trial of intradermal, controllable self-replicating ribonucleic acid vaccine EXG-5003 against SARS-CoV-2 Koseki et al. 2023 Vaccines 11, 1767
Science Immunology
Science Immunology
IMM-BCP-01, a patient-derived anti-SARS-CoV-2 antibody cocktail, is active across variants of concern including Omicron BA.1 and BA.2 Nikitin et al. 2022 Science Immunology 7, eabl9943
Vaccine
Vaccine
Pan-SARS neutralizing responses after third boost vaccination in non-human primate immunogenicity model Kalnin et al. 2022 Vaccine 40, 1289-1298Filoviruses and other viruses
Cell Reports
Cell Reports
Convergence of a common solution for broad ebolavirus neutralization by glycan cap directed human antibodies Murin et al. 2021 Cell Reports 35, 108984